O6-alkylguanine DNA-alkyltransferase in Breast Tumours
Author Information
Author(s): Clemons M J, Bibby M C, El Teraifi H, Forster G, Kelly J, Banerjee S, Cadman B, Ryder W D J, Howell A, Margison G P
Primary Institution: Cancer Research UK Department of Medical Oncology, Christie Hospital
Hypothesis
Can O6-alkylguanine DNA-alkyltransferase expression in breast tumours predict the behaviour of the malignancy?
Conclusion
Most breast tumours express high levels of O6-alkylguanine DNA-alkyltransferase, but its expression does not correlate with established clinical prognostic indicators.
Supporting Evidence
- Most breast tumours expressed high levels of O6-alkylguanine DNA-alkyltransferase.
- Immunohistochemical analysis showed marked variation in expression between individuals and within individual tumours.
- O6-alkylguanine DNA-alkyltransferase activity significantly correlated with immunohistochemical staining intensity.
Takeaway
This study looked at a special protein in breast cancer cells that helps them resist certain treatments, finding that while many cells have a lot of this protein, it doesn't help doctors predict how the cancer will behave.
Methodology
O6-alkylguanine DNA-alkyltransferase expression was measured using biochemical and immunohistochemical techniques in breast tumour samples.
Limitations
The study did not find a correlation between O6-alkylguanine DNA-alkyltransferase levels and established clinical prognostic indicators.
Participant Demographics
The study included 61 patients with primary breast tumours, primarily ductal carcinomas.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website